Autologous hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: treatment outcome and prognostic factor analysis.

@article{Shi2015AutologousHS,
  title={Autologous hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: treatment outcome and prognostic factor analysis.},
  author={Youwu Shi and Shengyu Zhou and Xiaohui He and Xiaohong Han and Shikai Wu and Feng Pan and Peng Liu and Yinyu Liu and Yingheng Lei and Hongzhi Zhang and Jianliang Yang and Yan Qin and Changgong Zhang and Sheng Yang and Liya Zhao and Kehuan Luo and Guanqing Wu and Yan Sun and Yuankai Shi},
  journal={Chinese journal of cancer research = Chung-kuo yen cheng yen chiu},
  year={2015},
  volume={27 1},
  pages={66-73}
}
OBJECTIVE The study evaluated the effectiveness of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of lymphoblastic lymphoma (LL). METHODS We retrospectively analyzed the data from 41 patients with chemotherapy-sensitive LL who underwent hematopoietic stem cell transplantation (HSCT) from December 1989 to December 2009 in a single institution. RESULTS HSCT was conducted as first-line consolidation therapy and salvage therapy in 36 and 5 patients, respectively… CONTINUE READING
1 Extracted Citations
0 Extracted References
Similar Papers